The Emmes Company

VaxTrials is a clinical research organization focused on providing innovative solutions for the management and monitoring of vaccination clinical trials. The company offers a comprehensive range of services, including project feasibility assessment, site management and monitoring, clinical supplies management, pharmacovigilance, and safety and medical monitoring. By delivering these specialized services, VaxTrials aims to facilitate the effective execution of vaccine trials, ultimately contributing to the eradication of preventable diseases.

Essex Management specializes in biomedical informatics and health information technology services, catering to federal government entities, research institutions, and private sector clients. The company offers a comprehensive range of services, including program and project management, systems design and engineering, and expertise in computational biology and bioinformatics. Essex Management focuses on optimizing clients' investments in information technology and informatics, aiming to enhance outcomes for patients and clinicians. Their capabilities encompass data management, genetic sequencing, cloud services, machine learning, and integrated process automation, among others. Through its diverse offerings, Essex Management strives to deliver tailored solutions that meet the evolving needs of the life sciences sector.

Clinical Edge offers Visual Acuity Examiner and Visual Acuity Room Certification to ensure quality and consistency amongst clinical sites participating in the conduct of Ophthalmology drug, biologic, and device trials.

Casimir is a contract research organization that emphasizes the patient's perspective in its clinical studies, particularly in the context of rare diseases. The company utilizes innovative approaches, such as virtual trials and remote assessments, to enhance understanding of disease progression and treatment effects. By focusing on qualitative research, Casimir aims to capture the real-world impact of treatment interventions on patient quality of life through intelligent outcome measures. This commitment to prioritizing the patient experience allows Casimir to contribute valuable insights into the effectiveness of medical treatments.

Institut Dr. Schauerte is a full-service contract research organization (CRO) based in Munich, specializing in late-phase, non-interventional studies, including registry and post-market clinical follow-up (PMCF) studies. The company focuses on providing tailored solutions for complex study designs that go beyond standard offerings, addressing the specific needs of investigator-initiated trials (IITs). By leveraging an intuitive and secure E-clinical research platform, Institut Dr. Schauerte supports innovation in public health and biopharmaceutical sectors, facilitating the advancement of healthcare through rigorous clinical research services.

Orphan Reach is a global, full-service contract research organization (CRO) specializing in clinical research for rare diseases. The company is dedicated to supporting orphan drug developers by offering tailored services that adapt to their specific needs, facilitating the drug development process from early trials to marketing authorization. Orphan Reach provides a comprehensive range of services, including project management, clinical monitoring, safety and pharmacovigilance, quality assurance, data management, and biostatistics. Its expertise lies in managing the unique challenges associated with small patient populations in the rare disease sector, allowing clients to navigate the complexities of clinical trials effectively. By focusing on patient-centric solutions, Orphan Reach aims to enhance the drug development process, ultimately benefiting both researchers and patients.

Neox s.r.o. is a contract research organization based in Prague, Czechia, that provides comprehensive clinical research support services. Established in 1995, Neox specializes in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies across Europe and the United States. The organization offers a wide range of services covering all phases of drug development, including medical writing, site contracting, clinical monitoring, project management, pharmacovigilance, and regulatory support. Neox also caters to medical device development and real-world evidence/data management. With years of experience and an understanding of local requirements, the company emphasizes optimal trial settings to enhance patient enrollment. Neox operates in multiple countries, including Austria, Belgium, Germany, and the United Kingdom, ensuring a broad geographical reach for its clinical research activities. As of December 2020, Neox serves as a subsidiary of The Emmes Company, LLC.